This next generation GPU chip from Nvidia could boost the company's revenue by 30% and decimate competition; here's everything about the chip Ivar AI

Ambcrypto.com

Crypto market cap surpasses France, UK GDPs – India, Japan next

Fark.com

China is surrounding Taiwan for some unknown reason which they aren't at liberty to discuss [Scary]

CryptoGlobe

Crypto Investment Funds Shatter Records with $3.85 Billion in Weekly Inflows, with ETH and XRP Standing Out

ZyCrypto

Shiro Neko Hits $1 Billion Market Cap on First Trading Day

Biztoc.com

Stock Markets Extends Record Highs, US Labor Market Recovers, Bitcoin Hits $100,000: This Week In The Markets

Xataka.com.co

Estados Unidos y Colombia lanzan alianza de seguridad para combatir el crimen organizado con drones

The Punch

Altseason Coming: Cardano, Solana, and New Altcoin Posed for Mind-blowing Gains

Biztoc.com

US Strategic Bitcoin Reserve Would Cause Tectonic Shifts In Personal Finance, Researcher Predicts

BeInCrypto

La capitalización realizada de Ethereum registra máximo histórico y sugiere problemas para los bajistas de ETH

Www.abc.es

La carta secreta de Putin, el Cosmos 2553, precursor de un arma espacial sin precedentes que amenazaría al mundo

The Times of India

China sends largest naval fleet in decades to region, threat level severe, Taiwan says

Robb Report

Google Just Made a Breakthrough in Quantum Computing With Its New Chip

The Times of India

Indian entertainment-media industry to grow 8.3% CAGR to reach Rs 3.7 trillion by 2028: PwC report

Business Insider

Alphabet stock adds $136 billion in market value after it unveils quantum computing breakthrough

Shtfplan.com

WEF Survey Shows That Business Leaders Are Deeply Concerned That A Global Recession Is Coming

Biztoc.com

XRP Price Rally Expected as Ripple CEO Announces ’60 Minutes’ Air Date

$Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma$

GlobeNewswire

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

$Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients$

GlobeNewswire

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients